Clinical trial

FAP-targeted PET/NIR in Lung Malignant Tumors

NCT07498933

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-06-03

PhaseN/A

Study timeline

Study start (actual)2025-06-03Date precision: day

Registry last updated2026-04-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancerunresolved

PET/CTunresolved

Neoadjuvant Therapyunresolved

Interventions

PET/CT scansDIAGNOSTIC_TEST

Sponsors & collaborators

Peking University People's Hospitallead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07498933 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.